Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study
Aims and background: Despite the support of the Global Alliance for Vaccines and Immunization, developing countries still struggle to afford inactivated polio vaccine (IPV). This study was undertaken to evaluate and compare the serological status of infants being offered two doses of intradermal fra...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jaypee Brothers Medical Publisher
2024-03-01
|
| Series: | Pediatric Infectious Disease |
| Subjects: | |
| Online Access: | https://www.pidjournal.com/doi/PID/pdf/10.5005/jp-journals-10081-1418 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825206220308348928 |
|---|---|
| author | Kunal Kumar Sangita Yadav Raghvendra Singh Archana Thakur |
| author_facet | Kunal Kumar Sangita Yadav Raghvendra Singh Archana Thakur |
| author_sort | Kunal Kumar |
| collection | DOAJ |
| description | Aims and background: Despite the support of the Global Alliance for Vaccines and Immunization, developing countries still struggle to afford inactivated polio vaccine (IPV). This study was undertaken to evaluate and compare the serological status of infants being offered two doses of intradermal fractional inactivated polio vaccine (ID-f-IPV) vs a single full dose administered intramuscularly (IM-SD-IPV) in conjunction with routine bivalent oral poliovirus vaccine (bOPV).
Materials and methods: This prospective cross-sectional study was conducted in an Indian tertiary care healthcare center. The study consisted of 80 participants, with 40 in each group. The study measured the levels of antibodies using human poliovirus (PV) antibody immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) kits and identified seroprotection as the presence of antibody >1:8 dilution. Seroconversion was described as a fourfold rise in antibody titers after 4 weeks.
Results: Pre- and postimmunization mean antibody titers (MAT) in pg/mL against types I, II, and III PVs in the ID group were 192.26 ± 49.5, 162.96 ± 34.1, 131.32 ± 38.4, and 1743.58 ± 391.6, 1272.10 ± 341.3, 1105.71 ± 331.1, respectively. However, in the IM group, they were 523.83 ± 102.5, 209.47 ± 57.3, 426.57 ± 61.7, 2101.32 ± 282.1, 1033.08 ± 226.1, and 1381.04 ± 308.3, respectively. Around 100% of participants in both groups were seroprotected at pre- and postimmunization levels. Seroconversion against types I, II, and III serotypes in the ID-f-IPV group was 100% each, while in the IM-SD-IPV group, it was 62.5, 87.5, and 55%, respectively.
Conclusion: The seroconversion rates of f-IPV were superior to the full dose IPV and may be a cost-effective choice for low- and middle-income countries. |
| format | Article |
| id | doaj-art-34fb63ef12a443969164833e7663693c |
| institution | Kabale University |
| issn | 2582-4988 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | Jaypee Brothers Medical Publisher |
| record_format | Article |
| series | Pediatric Infectious Disease |
| spelling | doaj-art-34fb63ef12a443969164833e7663693c2025-02-07T11:19:55ZengJaypee Brothers Medical PublisherPediatric Infectious Disease2582-49882024-03-0161141810.5005/jp-journals-10081-14184Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control StudyKunal Kumar0Sangita Yadav1Raghvendra Singh2Archana Thakur3Department of Pediatrics, Maulana Azad Medical College; Lok Nayak & Associated Hospitals, University of Delhi, Delhi, IndiaSangita Yadav, Department of Pediatrics, Maulana Azad Medical College; Lok Nayak & Associated Hospitals, University of Delhi, Delhi, India, Phone: +91 9968604307Department of Pediatrics, Maulana Azad Medical College; Lok Nayak & Associated Hospitals, University of Delhi, Delhi, IndiaDepartment of Microbiology, G B Pant Institute of Postgraduate Medical Education and Research, University of Delhi, Delhi, IndiaAims and background: Despite the support of the Global Alliance for Vaccines and Immunization, developing countries still struggle to afford inactivated polio vaccine (IPV). This study was undertaken to evaluate and compare the serological status of infants being offered two doses of intradermal fractional inactivated polio vaccine (ID-f-IPV) vs a single full dose administered intramuscularly (IM-SD-IPV) in conjunction with routine bivalent oral poliovirus vaccine (bOPV). Materials and methods: This prospective cross-sectional study was conducted in an Indian tertiary care healthcare center. The study consisted of 80 participants, with 40 in each group. The study measured the levels of antibodies using human poliovirus (PV) antibody immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) kits and identified seroprotection as the presence of antibody >1:8 dilution. Seroconversion was described as a fourfold rise in antibody titers after 4 weeks. Results: Pre- and postimmunization mean antibody titers (MAT) in pg/mL against types I, II, and III PVs in the ID group were 192.26 ± 49.5, 162.96 ± 34.1, 131.32 ± 38.4, and 1743.58 ± 391.6, 1272.10 ± 341.3, 1105.71 ± 331.1, respectively. However, in the IM group, they were 523.83 ± 102.5, 209.47 ± 57.3, 426.57 ± 61.7, 2101.32 ± 282.1, 1033.08 ± 226.1, and 1381.04 ± 308.3, respectively. Around 100% of participants in both groups were seroprotected at pre- and postimmunization levels. Seroconversion against types I, II, and III serotypes in the ID-f-IPV group was 100% each, while in the IM-SD-IPV group, it was 62.5, 87.5, and 55%, respectively. Conclusion: The seroconversion rates of f-IPV were superior to the full dose IPV and may be a cost-effective choice for low- and middle-income countries.https://www.pidjournal.com/doi/PID/pdf/10.5005/jp-journals-10081-1418inactivated poliovirus vaccinemean antibody titersseroconversionseroprotection |
| spellingShingle | Kunal Kumar Sangita Yadav Raghvendra Singh Archana Thakur Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study Pediatric Infectious Disease inactivated poliovirus vaccine mean antibody titers seroconversion seroprotection |
| title | Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study |
| title_full | Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study |
| title_fullStr | Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study |
| title_full_unstemmed | Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study |
| title_short | Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study |
| title_sort | immunogenicity of two fractional inactivated poliovirus vaccine doses vs single intramuscular inactivated poliovirus vaccine dose in infants of low and middle income countries a prospective case control study |
| topic | inactivated poliovirus vaccine mean antibody titers seroconversion seroprotection |
| url | https://www.pidjournal.com/doi/PID/pdf/10.5005/jp-journals-10081-1418 |
| work_keys_str_mv | AT kunalkumar immunogenicityoftwofractionalinactivatedpoliovirusvaccinedosesvssingleintramuscularinactivatedpoliovirusvaccinedoseininfantsoflowandmiddleincomecountriesaprospectivecasecontrolstudy AT sangitayadav immunogenicityoftwofractionalinactivatedpoliovirusvaccinedosesvssingleintramuscularinactivatedpoliovirusvaccinedoseininfantsoflowandmiddleincomecountriesaprospectivecasecontrolstudy AT raghvendrasingh immunogenicityoftwofractionalinactivatedpoliovirusvaccinedosesvssingleintramuscularinactivatedpoliovirusvaccinedoseininfantsoflowandmiddleincomecountriesaprospectivecasecontrolstudy AT archanathakur immunogenicityoftwofractionalinactivatedpoliovirusvaccinedosesvssingleintramuscularinactivatedpoliovirusvaccinedoseininfantsoflowandmiddleincomecountriesaprospectivecasecontrolstudy |